http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9965888-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd46a8394d53168f6117480fc93585a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_848330c9e0cdee1b04ce66f16e789fd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9b1bdf9182bc3e7e5202f609c405812
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-147777
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-142222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-042
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-33
filingDate 1999-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba5a491ce4c7b78a9b0326bee5ee4b06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f871bfb57de036628929ebb595de53db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fca3e8dcfa0dc175f90107cf8c840943
publicationDate 2000-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9965888-A3
titleOfInvention A reference compound for use in the analysis of levosimendan batches
abstract The present invention relates to a pyridazinyl derivative (I) and its use as a reference compound in the determination of potentially genotoxic impurities in levosimendan samples. The invention also relates to an analytic method for the determination of potentially genotoxic impurities in levosimendan samples wherein (I) is used as a reference compound. Levosimendan is a medicament useful in the treatment of heart failure.
priorityDate 1998-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0383449-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0359439-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9735841-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226461901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502430

Total number of triples: 32.